Market Research News Global Anti-Viral Drug Market (2016-2024)- Researc | Page 2

Global Anti-Viral Drug Market Overview
Anti-Viral Drug Market By Application (HIV Treatment, Hepatitis Treatment, Herpes
Treatment, Influenza Treatment, Others) By Type (Generic Drugs, Branded Drugs) By
End User (Hospitals, Clinics, Others) and Region - Global Forecast 2016 to 2024.
Anti-viral drugs refer to the class of antimicrobials which are used specifically for the
treatment of viral infections. Anti-viral drugs are formulated to treat HIV, hepatitis
virus, influenza and herpes virus. These anti-viral drugs can be used only for specific
disease.
Market Size and Forecast
Global Anti-Viral Drug Market is anticipated to flourish at a CAGR of 5.9% over the
forecast period. Further, the market of anti-viral drugs accounted for USD 31.2
Billion in 2016 and is projected to garner USD 42.3 by the end of 2024. Rising
prevalence of viral infections and diseases across the globe is expected to increase
the demand for anti-viral drugs globally.
In the regional platform, North America dominated the overall market of anti-viral
drugs in 2016. Further, North America market is expected to continue its dominance
over the forecast period on the account of rising healthcare expenditure.
Additionally, presence of highly developed healthcare infrastructure and rising
awareness about the viral infections is expected to fuel the growth of Anti-Viral
Drug Market in the North America region. U.S. is expected to be the major
contributor to the growth of anti-viral drugs owing to the presence of major key
players.
Asia Pacific is anticipated to witness robust growth over the forecast period 2017-
2024. This growth can be attributed to the increasing number of virus infected
people and rising disposable income of the population.
Copyright © Research Nester